After-Hours Movers 10/25: (QCOR) (PNRA) (FFIV) (CTS) Higher; (HGSI) (AMZN) (CENX) Lower
Tweet
Share
E-mail
Get Alerts QCOR Hot Sheet
Join SI Premium – FREE
Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) 13% HIGHER; reported Q3 EPS of $0.37, $0.11 better than the analyst estimate of $0.26. Revenue for the quarter came in at $59.8 million versus the consensus estimate of $53.42 million.
Human Genome Sciences, Inc. (NASDAQ: HGSI) 11.3% LOWER; reported Q3 loss of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $34 million versus the consensus estimate of $37.31 million. In previous guidance, originally provided in February 2011, HGS expected cash and investments at year-end 2011 to total between $550 million and $650 million. The Company now expects cash and investments at year-end 2011 to total between $440 million and $470 million, net of $79 million principal amount and interest paid upon maturity of the 2011 convertible debt.
Amazon.com (NASDAQ: AMZN) 11% LOWER; reported Q3 EPS of $0.14, vs. the analyst estimate of $0.24. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $10.93 billion. Sees Q4 sales $16.45-$18.65 billion, vs. the consensus of $18.16 billion.
Panera Bread Co. (NASDAQ: PNRA) 9.8% HIGHER; reported Q3 EPS of $0.97, $0.03 better than the analyst estimate of $0.94. Revenue for the quarter came in at $453 million versus the consensus estimate of $446.97 million. Panera Bread Co. sees Q4 2011 EPS of $1.39-$1.41, versus the consensus of $1.37. Panera Bread Co. sees FY2012 EPS of $5.38-$5.48, versus the consensus of $5.29.
F5 Networks, Inc. (NASDAQ: FFIV) 7% HIGHER; reported Q4 EPS of $1.06, $0.08 better than the analyst estimate of $0.98. Revenue for the quarter came in at $314.6 million versus the consensus estimate of $308.51 million. F5 Networks, Inc. sees Q1 2012 EPS of $0.99-$1.01, versus the consensus of $1.01. F5 Networks, Inc. sees Q1 2012 revenue of $315-$320 million, versus the consensus of $319.7 million.
CTS Corp. (NYSE: CTS) 6% HIGHER; reported Q3 EPS of $0.17, $0.01 better than the analyst estimate of $0.16. Revenue for the quarter came in at $146.1 million versus the consensus estimate of $147.22 million. CTS Corp. sees FY2011 EPS of $0.68-$0.71, versus the consensus of $0.70.
Century Aluminum Co (NASDAQ: CENX) 6% LOWER; reported Q3 EPS of ($0.07), which may not compare to the analyst estimate of $0.15. Revenue for the quarter came in at $345.6 million versus the consensus estimate of $352.5 million.
Sunoco Logistics Partners L.P. (NYSE: SXL) 5.2% HIGHER; reported Q3 EPS of $2.34, which may not compare to the analyst estimate of $1.70. Revenue for the quarter came in at $2.85 billion versus the consensus estimate of $2.02 billion.
Broadcom Corp (NASDAQ: BRCM) 5.2% LOWER; reported Q3 EPS of $0.82, $0.06 better than the analyst estimate of $0.76. Revenue for the quarter came in at $1.96 billion versus the consensus estimate of $1.95 billion. Sees Q4 sales of $1.7-$1.8 billion, which compares to the Street estimate of $2.01 billion. The company sees adj-gross margins flat to down slightly from the third quarter.
iRobot Corporation (NASDAQ: IRBT) 4.9% HIGHER; reported Q3 EPS of $0.50, $0.24 better than the analyst estimate of $0.26. Revenue for the quarter came in at $120.4 million versus the consensus estimate of $119.14 million. Sees Q4 2011 EPS of $0.26-$0.30, versus the consensus of $0.29. Sees Q4 2011 revenue of $130-$135 million, versus the consensus of $132.88 million. Sees FY2011 EPS of $1.32-$1.36, versus prior guidance of $1.04-$1.10 and the consensus of $1.11. Sees FY2011 revenue of $465-$470 million, versus prior guidance of $460-$470 million and the consensus of $470.88 million.
Manitowoc Co. (NYSE: MTW) 4.8% HIGHER; reported Q3 EPS of $0.18, $0.01 better than the analyst estimate of $0.17. Revenue for the quarter came in at $935.4 million versus the consensus estimate of $935.14 million.
FMC Technologies, Inc. (NYSE: FTI) 4.7% LOWER; reported Q3 EPS of $0.50, $0.04 better than the analyst estimate of $0.46. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.3 billion. FMC Technologies, Inc. sees FY2011 EPS of $1.70-$1.75, versus the consensus of $1.72.
TJX (NYSE: TJX) 4.7% LOWER; sees Q3 EPS solidly in the middle of its prior $1.03-$1.07 range, sees sales near the middle of the previously-issued guidance. Sees FY12 adj-EPS of $3.89-$3.97, which compares to the Street estimate of $3.98.
Chigago Bridge & Iron (NYSE: CBI) 4.3% HIGHER; reported Q3 EPS of $0.72, $0.07 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.17 billion.
MetLife (NYSE: MET) 4.3% LOWER; the Fed rejected the company's plan seeking approval to resume its stock repurchase program, as well as raise its quarterly dividend. The Fed said these capital actions first need to be tested under a "revised scenario."
McKesson Corp. (NYSE: MCK) 3.9% HIGHER; reported Q2 EPS of $1.63, $0.23 better than the analyst estimate of $1.40. Revenue for the quarter came in at $30.2 billion versus the consensus estimate of $29.48 billion. McKesson Corp. sees FY2012 EPS of $6.19-$6.39, versus prior guidance of $6.09-$6.29 and the consensus of $6.23.
Nabors Industries Ltd. (NYSE: NBR) 3.5% HIGHER; reported Q3 EPS of $0.44, $0.04 better than the analyst estimate of $0.40. Revenue for the quarter came in at $1.62 billion versus the consensus estimate of $1.5 billion.
Express Scripts, Inc. (NASDAQ: ESRX) 3% HIGHER; reported Q3 adjusted EPS of $0.79, $0.02 better than the analyst estimate of $0.77. Revenue for the quarter came in at $11.57 billion versus the consensus estimate of $11.26 billion.
USANA Health Sciences, Inc. (NASDAQ: USNA) 2% HIGHER; reported Q3 EPS of $0.81, $0.05 better than the analyst estimate of $0.76. Revenue for the quarter came in at $143.5 million versus the consensus estimate of $142.3 million. USANA Health Sciences, Inc. sees FY2011 EPS of $3.20-$3.25, versus prior guidance of $3.05-$3.10 and the consensus of $3.10. USANA Health Sciences, Inc. sees FY2011 revenue of $577-$581 million, versus prior guidance of $565-$575 million and the consensus of $578.03 million.
Boston Properties, Inc. (NYSE: BXP) 2% HIGHER; reported Q3 FFO of $1.28, $0.04 better than the analyst estimate of $1.24. Revenue for the quarter came in at $452.4 million versus the consensus estimate of $426.54 million. Sees Q4 FFO of $1.18-$1.20, which compares to the Street estimate of $1.24.
Human Genome Sciences, Inc. (NASDAQ: HGSI) 11.3% LOWER; reported Q3 loss of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $34 million versus the consensus estimate of $37.31 million. In previous guidance, originally provided in February 2011, HGS expected cash and investments at year-end 2011 to total between $550 million and $650 million. The Company now expects cash and investments at year-end 2011 to total between $440 million and $470 million, net of $79 million principal amount and interest paid upon maturity of the 2011 convertible debt.
Amazon.com (NASDAQ: AMZN) 11% LOWER; reported Q3 EPS of $0.14, vs. the analyst estimate of $0.24. Revenue for the quarter came in at $10.9 billion versus the consensus estimate of $10.93 billion. Sees Q4 sales $16.45-$18.65 billion, vs. the consensus of $18.16 billion.
Panera Bread Co. (NASDAQ: PNRA) 9.8% HIGHER; reported Q3 EPS of $0.97, $0.03 better than the analyst estimate of $0.94. Revenue for the quarter came in at $453 million versus the consensus estimate of $446.97 million. Panera Bread Co. sees Q4 2011 EPS of $1.39-$1.41, versus the consensus of $1.37. Panera Bread Co. sees FY2012 EPS of $5.38-$5.48, versus the consensus of $5.29.
F5 Networks, Inc. (NASDAQ: FFIV) 7% HIGHER; reported Q4 EPS of $1.06, $0.08 better than the analyst estimate of $0.98. Revenue for the quarter came in at $314.6 million versus the consensus estimate of $308.51 million. F5 Networks, Inc. sees Q1 2012 EPS of $0.99-$1.01, versus the consensus of $1.01. F5 Networks, Inc. sees Q1 2012 revenue of $315-$320 million, versus the consensus of $319.7 million.
CTS Corp. (NYSE: CTS) 6% HIGHER; reported Q3 EPS of $0.17, $0.01 better than the analyst estimate of $0.16. Revenue for the quarter came in at $146.1 million versus the consensus estimate of $147.22 million. CTS Corp. sees FY2011 EPS of $0.68-$0.71, versus the consensus of $0.70.
Century Aluminum Co (NASDAQ: CENX) 6% LOWER; reported Q3 EPS of ($0.07), which may not compare to the analyst estimate of $0.15. Revenue for the quarter came in at $345.6 million versus the consensus estimate of $352.5 million.
Sunoco Logistics Partners L.P. (NYSE: SXL) 5.2% HIGHER; reported Q3 EPS of $2.34, which may not compare to the analyst estimate of $1.70. Revenue for the quarter came in at $2.85 billion versus the consensus estimate of $2.02 billion.
Broadcom Corp (NASDAQ: BRCM) 5.2% LOWER; reported Q3 EPS of $0.82, $0.06 better than the analyst estimate of $0.76. Revenue for the quarter came in at $1.96 billion versus the consensus estimate of $1.95 billion. Sees Q4 sales of $1.7-$1.8 billion, which compares to the Street estimate of $2.01 billion. The company sees adj-gross margins flat to down slightly from the third quarter.
iRobot Corporation (NASDAQ: IRBT) 4.9% HIGHER; reported Q3 EPS of $0.50, $0.24 better than the analyst estimate of $0.26. Revenue for the quarter came in at $120.4 million versus the consensus estimate of $119.14 million. Sees Q4 2011 EPS of $0.26-$0.30, versus the consensus of $0.29. Sees Q4 2011 revenue of $130-$135 million, versus the consensus of $132.88 million. Sees FY2011 EPS of $1.32-$1.36, versus prior guidance of $1.04-$1.10 and the consensus of $1.11. Sees FY2011 revenue of $465-$470 million, versus prior guidance of $460-$470 million and the consensus of $470.88 million.
Manitowoc Co. (NYSE: MTW) 4.8% HIGHER; reported Q3 EPS of $0.18, $0.01 better than the analyst estimate of $0.17. Revenue for the quarter came in at $935.4 million versus the consensus estimate of $935.14 million.
FMC Technologies, Inc. (NYSE: FTI) 4.7% LOWER; reported Q3 EPS of $0.50, $0.04 better than the analyst estimate of $0.46. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.3 billion. FMC Technologies, Inc. sees FY2011 EPS of $1.70-$1.75, versus the consensus of $1.72.
TJX (NYSE: TJX) 4.7% LOWER; sees Q3 EPS solidly in the middle of its prior $1.03-$1.07 range, sees sales near the middle of the previously-issued guidance. Sees FY12 adj-EPS of $3.89-$3.97, which compares to the Street estimate of $3.98.
Chigago Bridge & Iron (NYSE: CBI) 4.3% HIGHER; reported Q3 EPS of $0.72, $0.07 better than the analyst estimate of $0.65. Revenue for the quarter came in at $1.26 billion versus the consensus estimate of $1.17 billion.
MetLife (NYSE: MET) 4.3% LOWER; the Fed rejected the company's plan seeking approval to resume its stock repurchase program, as well as raise its quarterly dividend. The Fed said these capital actions first need to be tested under a "revised scenario."
McKesson Corp. (NYSE: MCK) 3.9% HIGHER; reported Q2 EPS of $1.63, $0.23 better than the analyst estimate of $1.40. Revenue for the quarter came in at $30.2 billion versus the consensus estimate of $29.48 billion. McKesson Corp. sees FY2012 EPS of $6.19-$6.39, versus prior guidance of $6.09-$6.29 and the consensus of $6.23.
Nabors Industries Ltd. (NYSE: NBR) 3.5% HIGHER; reported Q3 EPS of $0.44, $0.04 better than the analyst estimate of $0.40. Revenue for the quarter came in at $1.62 billion versus the consensus estimate of $1.5 billion.
Express Scripts, Inc. (NASDAQ: ESRX) 3% HIGHER; reported Q3 adjusted EPS of $0.79, $0.02 better than the analyst estimate of $0.77. Revenue for the quarter came in at $11.57 billion versus the consensus estimate of $11.26 billion.
USANA Health Sciences, Inc. (NASDAQ: USNA) 2% HIGHER; reported Q3 EPS of $0.81, $0.05 better than the analyst estimate of $0.76. Revenue for the quarter came in at $143.5 million versus the consensus estimate of $142.3 million. USANA Health Sciences, Inc. sees FY2011 EPS of $3.20-$3.25, versus prior guidance of $3.05-$3.10 and the consensus of $3.10. USANA Health Sciences, Inc. sees FY2011 revenue of $577-$581 million, versus prior guidance of $565-$575 million and the consensus of $578.03 million.
Boston Properties, Inc. (NYSE: BXP) 2% HIGHER; reported Q3 FFO of $1.28, $0.04 better than the analyst estimate of $1.24. Revenue for the quarter came in at $452.4 million versus the consensus estimate of $426.54 million. Sees Q4 FFO of $1.18-$1.20, which compares to the Street estimate of $1.24.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- These 2 companies are best positioned to scale in U.S. AV market
- Medtronic (MDT) Declares $0.72 Quarterly Dividend; 3.1% Yield
- Cincinnati Financial (CINF) Declares $0.94 Quarterly Dividend; 2.2% Yield
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Dividend, After-Hours Movers, Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
